Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy-Reference-Cited by-同舟云学术

Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy

Published:2004 Issue:5 Volume:109 Page:703-709
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Basu Saurajyoti,Brown John E.,Flannigan G. Michael,Gill Jason H.,Loadman Paul M.,Martin Sandie W.,Naylor Brian,Scally Andrew J.,Seargent Jill M.,Shah Tariq,Puri Rajiv,Phillips Roger M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Selection of markers to predict tumour response or survival: description of a novel approach

2. Gene expression profiling predicts clinical outcome of breast cancer

3. Enzyme directed bioreductive drug development. In: eds. Selective activation of drugs by redox processes. New York: Plenum Publishing Corp., 1990. 173-191.

4. A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer;Cancer Chemotherapy and Pharmacology;2019-03-13

2. Synthesis of Novel Diaziridinyl Quinone Isoxazole Hybrids and Evaluation of Their Anti-Cancer Activity as Potential Tubulin-Targeting Agents;Drug Research;2019-01-17

3. Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy;Pharmacogenetics and Genomics;2017-09

4. Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance;DNA Repair;2017-06

5. Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone – A novel class of compounds with potent activity against acute myeloid leukemia cells;Bioorganic & Medicinal Chemistry Letters;2017-01